Approximately 80% of ARMS cases are characterized by the tumor-specific chromosomal translocations [t(2;13) or t(1;13)] that generate a PAX3::FOXO1 or a PAX7::FOXO1 gene fusion (2, 11, 12). This evidence concerns the gene FOXO1 and alveolar rhabdomyosarcoma.